Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹30,730.7
₹65,301 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,618.5
₹32,708 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹474.6
₹7,470 Cr
Pharmaceuticals & Drugs
₹748.6
₹6,784 Cr
Pharmaceuticals & Drugs
₹278.9
₹3,120 Cr
Pharmaceuticals & Drugs
₹339.8
₹3,101 Cr
Pharmaceuticals & Drugs
₹98.5
₹2,529 Cr
Pharmaceuticals & Drugs
₹811.3
₹463 Cr
Pharmaceuticals & Drugs
₹56.1
₹273 Cr
Pharmaceuticals & Drugs
₹33.7
₹96 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,618.5
₹4,532 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹474.6
₹4,145 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹339.8
₹2,330 Cr
Pharmaceuticals & Drugs
₹748.6
₹2,057 Cr
Pharmaceuticals & Drugs
₹278.9
₹628 Cr
Pharmaceuticals & Drugs
₹98.5
₹211 Cr
Pharmaceuticals & Drugs
₹30,730.7
₹6,243 Cr
Pharmaceuticals & Drugs
₹56.1
₹51 Cr
Pharmaceuticals & Drugs
₹811.3
₹360 Cr
Pharmaceuticals & Drugs
₹33.7
₹576 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,618.5
₹898 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹474.6
₹389 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹748.6
₹249 Cr
Pharmaceuticals & Drugs
₹339.8
₹153 Cr
Pharmaceuticals & Drugs
₹98.5
₹142 Cr
Pharmaceuticals & Drugs
₹278.9
₹137 Cr
Pharmaceuticals & Drugs
₹30,730.7
₹1,334 Cr
Pharmaceuticals & Drugs
₹56.1
₹2 Cr
Pharmaceuticals & Drugs
₹811.3
₹40 Cr
Pharmaceuticals & Drugs
₹33.7
₹6 Cr

You may also like the below Video Courses